Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Loxo Oncology (LOXO) Announces Common Offering
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Loxo Oncology (LOXO): Solid Data On larotrectinib From ASCO - Cowen
-
Loxo Oncology to Present at Cowen and Company 37th Annual Health Care Conference
-
Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 3.87M Share Offering at $31
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) to Offers Shares of Common Stock
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 1.68M Common Stock Offering at $21.50/Share
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) Plans Common Stock Offering
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Loxo Oncology to Present at Cowen and Company 36th Annual Health Care Conference
-
Loxo Oncology Announces the Closing of Its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Loxo Oncology (LOXO) Prices 2.5M Common Follow-on at $26.50/Share
-
Loxo Oncology Prices Follow-On Offering of Common Stock
-
Loxo Oncology (LOXO) Commences 2M Share Common Stock Offering
-
Loxo Oncology Announces Proposed Public Offering of Common Stock
-
Cowen Starts Loxo Oncology (LOXO) at Outperform
-
Loxo Oncology (LOXO) IPO Opens Flat, Trends Lower
-
Loxo Oncology (LOXO) Prices 5.26M Common IPO at $13/Share

